The addition of blocking anti-CD44 antibodies to CLL co-cultures with follicular dendritic cells reduced the survival of CLL cells, paralleled by decreased levels of the anti-apoptotic protein myeloid cell leukemia sequence 1 (Mcl-1) (64). The gene discussed is CD44; the disease is B-cell chronic lymphocytic leukemia.